TP53 and leukemia: Another study revealed the synergistic effect of triptolide and Nutlin-3a (an MDM2 inhibitor) in inhibiting cell proliferation and triggering mitochondrial-mediated apoptosis in vitro and ex vivo in wild-type p53 AML xenograft leukemia cells.